- Report
- October 2025
- 181 Pages
Global
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP
- Report
- September 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,439GBP
- Report
- December 2025
- 193 Pages
Global
From €5136EUR$5,850USD£4,481GBP
- Report
- March 2025
- 180 Pages
Global
From €3951EUR$4,500USD£3,447GBP
- Report
- September 2025
- 150 Pages
Global
From €2238EUR$2,549USD£1,953GBP
€2633EUR$2,999USD£2,297GBP
- Report
- January 2025
- 182 Pages
Global
From €4385EUR$4,995USD£3,826GBP
- Report
- July 2025
- 85 Pages
Global
From €3500EUR$4,271USD£3,161GBP
- Report
- January 2025
- 93 Pages
Europe
From €3029EUR$3,450USD£2,643GBP
- Report
- January 2025
- 88 Pages
North America
From €3029EUR$3,450USD£2,643GBP
- Report
- January 2025
- 73 Pages
Africa, Middle East
From €3029EUR$3,450USD£2,643GBP
- Report
- December 2024
- 88 Pages
Asia Pacific
From €3029EUR$3,450USD£2,643GBP
- Report
- August 2025
- 191 Pages
Global
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP
- Report
- November 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,949GBP
- Report
- November 2025
- 400 Pages
Global
From €3507EUR$3,995USD£3,060GBP
- Report
- October 2024
- 196 Pages
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP
- Report
- October 2024
- 195 Pages
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP
- Report
- June 2025
- 100 Pages
Global
From €5224EUR$5,950USD£4,558GBP
- Report
- November 2025
- 184 Pages
Global
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP
- Report
- November 2025
- 187 Pages
Global
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP
- Report
- November 2025
- 198 Pages
Global
From €3112EUR$3,545USD£2,715GBP
€3458EUR$3,939USD£3,017GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more